Search

everythinglearnresearchcommunity

for

Search:↓

Erdr1 could be a new marker for diagnosing hair loss.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Some wound-healing cells can turn into fat cells around new hair growth in mice.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Researchers created a new light source that improves chemical imaging by removing background noise.

Blocking CXXC5 speeds up diabetic wound healing by improving blood vessel growth and skin repair.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

The hair test for vitamin D could be a useful alternative to blood tests, providing a longer-term vitamin D status, but more research is needed.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Combining Traditional Chinese Medicine and Western medicine can improve symptoms, hormone levels, and pregnancy outcomes in Polycystic Ovary Syndrome patients, but more research is needed.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Baricitinib is effective and safe for treating severe alopecia areata.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.